Paul F. Lizzul - Sep 14, 2022 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Chief Medical Officer
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Stock symbol
ANAB
Transactions as of
Sep 14, 2022
Transactions value $
$0
Form type
4
Date filed
9/16/2022, 05:08 PM
Previous filing
Jun 27, 2022
Next filing
Jan 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Restricted Stock Unit Award $0 +12K $0.00 12K Sep 14, 2022 Common Stock 12K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time retention grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 50% of the total RSUs vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F3 In addition to the remaining options to purchase 12,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 215,000 shares of common stock, which options vest according to their terms, and (ii) 1,751 shares of common stock held directly.